News

To prevent the spread of inaccurate information, academic and health care institutions will need to equip scientists and clinicians to engage effectively on nontraditional media platforms.
Understanding today’s corporatization of U.S. health care requires seeing it from a historical perspective, as a process that began with a change in the business model of care delivery in the 1920s.
This Double Take video explores the link between certain strains of human papillomavirus and cancer and reviews the evidence ...
A 19-year-old woman with a history of depression and anxiety symptoms was admitted to the hospital because of seizure, ...
Children were recently discovered to have been exposed to high levels of lead in Milwaukee schools — the latest episode in an ongoing toxic pandemic. This time, no help was forthcoming from the CDC.
Audio Interview from the New England Journal of Medicine — Interview with Arthur Robin Williams on alcohol consumption in the United States and the effects of alcohol taxes.
After a year of clinical rotations in which a medical student learns to face death up close, her experience on a silent meditation retreat provides her with new perspective on death and life.
Audio Interview from the New England Journal of Medicine — Interview with Peter Marks on the disruption of traditional approaches to establishing Covid-19 vaccine policy in the United States.
The author describes the implementation of a clinical-care program involving pronuclear transfer to minimize the transmission of mitochondrial disease. He also describes the long pathway leading to ...
The author describes pronuclear transfer, a type of mitochondrial donation, which was made available to women with mitochondrial DNA disease in a reproductive care pathway implemented in Newcastle, ...
When someone is declared brain-dead during pregnancy, state laws regarding abortion, advance directives, and end-of-life care may all come into play. What should the deciding factors be?
To the Editor: In the API-CAT trial (April 10 issue),1 Mahé and colleagues confirm that a reduced dose of apixaban (2.5 mg twice daily) is noninferior to a full dose (5.0 mg) of the drug for ...